Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2018 2
2019 1
2020 4
2021 5
2022 8
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan.
Mukai R, Kataoka K, Tanaka K, Miyara Y, Maruko I, Nakayama M, Watanabe Y, Yamamoto A, Wakatsuki Y, Onoe H, Wakugawa S, Terao N, Hasegawa T, Hashiya N, Kawai M, Maruko R, Itagaki K, Honjo J, Okada AA, Mori R, Koizumi H, Iida T, Sekiryu T. Mukai R, et al. Among authors: terao n. Sci Rep. 2023 May 30;13(1):8747. doi: 10.1038/s41598-023-35759-4. Sci Rep. 2023. PMID: 37253802 Free PMC article.
Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration.
Kataoka K, Itagaki K, Hashiya N, Wakugawa S, Tanaka K, Nakayama M, Yamamoto A, Mukai R, Honjyo J, Maruko I, Kawai M, Miyara Y, Terao N, Wakatsuki Y, Onoe H, Mori R, Koizumi H, Sekiryu T, Iida T, Okada AA; for Japan AMD Research Consortium (JARC). Kataoka K, et al. Among authors: terao n. Graefes Arch Clin Exp Ophthalmol. 2024 Jan;262(1):43-51. doi: 10.1007/s00417-023-06222-x. Epub 2023 Sep 5. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37668741
CILIOCHOROIDAL EFFUSION IN CENTRAL SEROUS CHORIORETINOPATHY.
Terao N, Imanaga N, Wakugawa S, Sawaguchi S, Tamashiro T, Yamauchi Y, Koizumi H. Terao N, et al. Retina. 2022 Apr 1;42(4):730-737. doi: 10.1097/IAE.0000000000003376. Retina. 2022. PMID: 34907128 Free PMC article.
Scleral Thickness in Central Serous Chorioretinopathy.
Imanaga N, Terao N, Nakamine S, Tamashiro T, Wakugawa S, Sawaguchi K, Koizumi H. Imanaga N, et al. Among authors: terao n. Ophthalmol Retina. 2021 Mar;5(3):285-291. doi: 10.1016/j.oret.2020.07.011. Epub 2020 Jul 16. Ophthalmol Retina. 2021. PMID: 32683110 Free article.
Scleral Thickness in Steroid-Induced Central Serous Chorioretinopathy.
Sawaguchi S, Terao N, Imanaga N, Wakugawa S, Tamashiro T, Yamauchi Y, Koizumi H. Sawaguchi S, et al. Among authors: terao n. Ophthalmol Sci. 2022 Feb 8;2(2):100124. doi: 10.1016/j.xops.2022.100124. eCollection 2022 Jun. Ophthalmol Sci. 2022. PMID: 36249703 Free PMC article.
Distinct characteristics of central serous chorioretinopathy according to gender.
Yoneyama S, Fukui A, Sakurada Y, Terao N, Shijo T, Kusada N, Sugiyama A, Matsubara M, Fukuda Y, Kikushima W, Parikh R, Mabuchi F, Sotozono C, Kashiwagi K. Yoneyama S, et al. Among authors: terao n. Sci Rep. 2022 Jun 22;12(1):10565. doi: 10.1038/s41598-022-14777-8. Sci Rep. 2022. PMID: 35732691 Free PMC article.
26 results